A Study of Hetrombopag Combined With rhTPO in the Treatment of Cancer Therapy-induced Thrombocytopenia (CTIT) in Solid Tumor Patients.
Clinical trial NCT07334093 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07334093
- Sponsor
- Sun Yat-sen University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-31
- Primary completion
- 2027-11-15
- Enrollment
- 204
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.